17 Recruiting Fabry Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Fabry Disease
Top Recruiting Fabry Disease Studies
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
📍 Nephrology Clinic at Kirklin Clinic of UAB Hospital_Investigational Site Number: 8400011 — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
📍 University of Alabama at Birmingham - Nephrology Research Clinic — Birmingham, Alabama
View Study & Checklist ➔Long-Term Follow-up of Subjects Who Were Treated With ST-920
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
📍 University of California at San Diego — La Jolla, California
View Study & Checklist ➔A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
📍 University of Alabama -The Kirklin Clinic- Site Number : 8400010 — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
📍 Amicus Therapeutics, Inc. Pregnancy Registry — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of Patients With Fabry Disease (US Specific)
📍 UAB Nephrology Research Clinic at Paula Building — Birmingham, Alabama
View Study & Checklist ➔Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
📍 University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Fabry Disease Registry & Pregnancy Sub-registry
📍 University of Alabama Birmingham- Nephrology- Site Number : 840018 — Birmingham, Alabama
View Study & Checklist ➔A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
📍 Emory Genetics — Atlanta, Georgia
View Study & Checklist ➔A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Canadian Fabry Disease Initiative (CFDI) National Registry
📍 Alberta Children's Hospital — Calgary, Alberta
View Study & Checklist ➔A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
📍 Phoenix Children's — Phoenix, Arizona
View Study & Checklist ➔Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
📍 No physical study sites - Decentralized, web-based registry — Washington D.C., District of Columbia
View Study & Checklist ➔Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
📍 The Kirklin Clinic Of university of Alabama Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
📍 University Health Network — Toronto, Ontario
View Study & Checklist ➔